Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» TAK-101
TAK-101
Takeda acquires TAK-101 license from COUR in $420m deal
Pharmaceutical Business Review
Wed, 10/23/19 - 10:16 am
Takeda
COUR Pharmaceutical Development
CNP-101
TAK-101
celiac disease